Term ends Oct 7, 2031 · Medium confidence
20-year base term ends Oct 7, 2031
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 10,583,190), so the cap could be lower.
Oct 7, 2011
Oct 7, 2031
Feb 17, 2026
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 1 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 7, 2011, when application PCT/EP2011/067522, the earliest non-provisional in its chain, was filed (this one was filed Dec 16, 2024) | Oct 7, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,434,172, US 10,583,190, US 11,278,618, US 11,351,253, US 11,534,490, US 9,717,791) | resolves to Oct 7, 2031, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 7, 2031 | Medium confidence |
This family
| US 9,717,791 | In force May 2032 | May 2032 |
| US 10,583,190 | In force no later than Oct 2031 | no later than Oct 2031 |
| US 11,534,490 | In force Oct 2031 | Oct 2031 |
| Application 17/127,738 | Abandoned not computed | not computed |
| Application 17/165,724 | Abandoned not computed | not computed |
| Application 18/061,227 | Pending not computed | not computed |
| US 12,594,331 | In force Oct 2031 | Oct 2031 |
| US 12,551,554 | this patent Oct 2031 | Oct 2031 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 28, 2025 Reel 70369, frame 376 | Guettner, Achim; Machacek, Matthias; Papavassilis, Charis; Sander, Oliver | Novartis AG | Assignment of Assignor's Interest |
| Jun 11, 2026 Reel 75712, frame 291 | Novartis AG | Novartis Pharma AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,434,172, US 10,583,190, US 11,278,618, US 11,351,253, US 11,534,490, US 9,717,791, ends no earlier than this term, so it caps nothing.